Antimicrobial Resistance Among Pathogens Causing Bloodstream Infections: A Multicenter Surveillance Report Over 20 Years (1998–2017)

References

• Ripabelli G, Salzo A, Mariano A, et al.; Collaborative Group for HPPSiMR. Healthcare-associated infections point prevalence survey and antimicrobials use in acute care hospitals (PPS 2016-2017) and long-term care facilities (HALT-3): a comprehensive report of the first experience in Molise Region, Central Italy, and targeted intervention strategies. J Infect Public Health. 2019;12(4):509–515. doi:10.1016/j.jiph.2019.01.060.
   PubMed Web of Science ®Google Scholar
• Shi D, Anwar TM, Pan H, et al. Genomic determinants of pathogenicity and antimicrobial resistance for 60 global listeria monocytogenes isolates responsible for invasive infections. Front Cell Infect Microbiol. 2021;11:718840. doi:10.3389/fcimb.2021.718840
   Web of Science ®Google Scholar
• Hu F, Zhu D, Wang F, Wang M. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(suppl_2):S128–S34. doi:10.1093/cid/ciy657
   PubMed Web of Science ®Google Scholar
• Hubei Statistical Service. Statistical yearbook of the Province; regional analytical report, Hubei Region—Hubei statistical service. Available from: www.tjj.hubei.gov.cn. Accessed September 29, 2019.
   Google Scholar
• Iroh Tam PY, Musicha P, Kawaza K, et al. Emerging resistance to empiric antimicrobial regimens for pediatric bloodstream infections in Malawi (1998–2017). Clin Infect Dis. 2019;69(1):61–68. doi:10.1093/cid/ciy834
   PubMed Web of Science ®Google Scholar
• Musicha P, Cornick JE, Bar-Zeev N, et al. Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998–2016): a surveillance study. Lancet Infect Dis. 2017;17(10):1042–1052. doi:10.1016/S1473-3099(17)30394-8
   PubMed Web of Science ®Google Scholar
• Liu Y, Cui BC, Pi CM, et al. Analysis of prognostic risk factors of bloodstream infections in Beijing communities: a retrospective study from 2015 to 2019. Mediterr J Hematol Infect Dis. 2021;13(1):e2021060. doi:10.4084/MJHID.2021.060
   PubMed Web of Science ®Google Scholar
• Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–750. doi:10.1016/S1473-3099(14)70780-7
   PubMed Web of Science ®Google Scholar
• Tang X, Xiao M, Zhuo C, Xu Y, Zhong N. Multi-level analysis of bacteria isolated from inpatients in respiratory departments in China. J Thorac Dis. 2018;10(5):2666–2675. doi:10.21037/jtd.2018.04.46
   Web of Science ®Google Scholar
• Health and Family Planning Commission. Operating procedures of blood culture for clinical microbiology laboratory. WS/T 503, GB, GBT, GB/T: Chinese Standard; 2017.
   Google Scholar
• Weinstein MP, Murphy JR, Reller LB, Lichtenstein KA. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis. Rev Infect Dis. 1983;5(1):54–70. doi:10.1093/clinids/5.1.54
   PubMedGoogle Scholar
• Clinical and Laboratory Standards Institute. Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data, M39-A4. Wayne, PA: Clin Lab Stand Institute; 2014.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, Thirtieth Informational Supplement, M100-S30. Wayne, PA: Clin Lab Stand Institute; 2020.
   Google Scholar
• Gagliotti C, Balode A, Baquero F, et al. Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill. 2011;16(11). doi:10.2807/ese.16.11.19819-en
   Google Scholar
• Liu C, Xu M, Li X, et al. Trends in antimicrobial resistance in bloodstream infections at a large tertiary-care hospital in China: a 10-year retrospective study (2010–2019). J Glob Antimicrob Resist. 2021. doi:10.1016/j.jgar.2021.09.018
   Web of Science ®Google Scholar
• Tack B, Phoba MF, Van Puyvelde S, et al. Salmonella typhi from blood cultures in the Democratic Republic of the Congo: a 10-year surveillance. Clin Infect Dis. 2019;68(Suppl 2):S130–S137. doi:10.1093/cid/ciy1116
   PubMed Web of Science ®Google Scholar
• Crump JA, Sjolund-Karlsson M, Gordon MA, Parry CM. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive salmonella infections. Clin Microbiol Rev. 2015;28(4):901–937. doi:10.1128/CMR.00002-15
   PubMed Web of Science ®Google Scholar
• Buckle GC, Walker CL, Black RE. Typhoid fever and paratyphoid fever: systematic review to estimate global morbidity and mortality for 2010. J Glob Health. 2012;2(1):010401. doi:10.7189/jogh.02.010401
   PubMedGoogle Scholar
• Al-Emran HM, Eibach D, Krumkamp R, et al. A multicountry molecular analysis of salmonella enterica serovar typhi with reduced susceptibility to ciprofloxacin in Sub-Saharan Africa. Clin Infect Dis. 2016;62(Suppl 1):S42–S46. doi:10.1093/cid/civ788
   Web of Science ®Google Scholar
• Crump JA, Mintz ED. Global trends in typhoid and paratyphoid fever. Clin Infect Dis. 2010;50(2):241–246. doi:10.1086/649541
   PubMed Web of Science ®Google Scholar
• Msemo OA, Mbwana J, Mahende C, et al. Epidemiology and antimicrobial susceptibility of salmonella enterica bloodstream isolates among febrile children in a rural district in Northeastern Tanzania: a cross-sectional study. Clin Infect Dis. 2019;68(Suppl 2):S177–S82. doi:10.1093/cid/ciy1126
   Web of Science ®Google Scholar
• Cruz Espinoza LM, Nichols C, Adu-Sarkodie Y, et al. Variations of invasive salmonella infections by population size in Asante Akim North Municipal, Ghana. Clin Infect Dis. 2016;62(Suppl 1):S17–22. doi:10.1093/cid/civ787
   PubMed Web of Science ®Google Scholar
• Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet. 2012;379(9835):2489–2499. doi:10.1016/S0140-6736(11)61752-2
   PubMed Web of Science ®Google Scholar
• Uche IV, MacLennan CA, Saul A, Systematic A. Review of the incidence, risk factors and case fatality rates of Invasive Nontyphoidal Salmonella (iNTS) disease in Africa (1966 to 2014). PLoS Negl Trop Dis. 2017;11(1):e0005118. doi:10.1371/journal.pntd.0005118
   PubMed Web of Science ®Google Scholar
• Crump JA, Heyderman RS. A perspective on invasive salmonella disease in Africa. Clin Infect Dis. 2015;61(Suppl 4):S235–40. doi:10.1093/cid/civ709
   PubMed Web of Science ®Google Scholar
• Kariuki S, Gordon MA, Feasey N, Parry CM. Antimicrobial resistance and management of invasive Salmonella disease. Vaccine. 2015;33(Suppl 3):C21–9. doi:10.1016/j.vaccine.2015.03.102
   PubMed Web of Science ®Google Scholar
• Kalonji LM, Post A, Phoba MF, et al. Invasive salmonella infections at multiple surveillance sites in the Democratic Republic of the Congo, 2011–2014. Clin Infect Dis. 2015;61(Suppl 4):S346–53. doi:10.1093/cid/civ713
   Web of Science ®Google Scholar
• Oneko M, Kariuki S, Muturi-Kioi V, et al. Emergence of community-acquired, multidrug-resistant invasive nontyphoidal salmonella disease in Rural Western Kenya, 2009–2013. Clin Infect Dis. 2015;61(Suppl 4):S310–6. doi:10.1093/cid/civ674
   PubMed Web of Science ®Google Scholar
• Qiu YF, Nambiar RB, Xu XB, et al. Global genomic characterization of Salmonella enterica Serovar Telelkebir. Front Microbiol. 2021;12:704152. doi:10.3389/fmicb.2021.704152
   PubMed Web of Science ®Google Scholar
• Xu X, Chen Y, Pan H, et al. Genomic characterization of Salmonella uzaramo for human invasive infection. Microb Genom. 2020;6(7). doi:10.1099/mgen.0.000401
   Web of Science ®Google Scholar
• Wang P, Hu F, Xiong Z, et al. Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints. J Clin Microbiol. 2011;49(9):3127–3131. doi:10.1128/JCM.00222-11
   Web of Science ®Google Scholar
• Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20:1170–1175. doi:10.3201/eid2007.121004
   PubMed Web of Science ®Google Scholar
• Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Y, Yinnon AM, Assous MV. Mortality due to blaKPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2016;71:1083–1087. doi:10.1093/jac/dkv414
   PubMed Web of Science ®Google Scholar
• Gutierrez-Gutierrez B, Salamanca E, de Cueto M, et al. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. Lancet Infect Dis. 2017;17(7):726–734. doi:10.1016/S1473-3099(17)30228-1
   PubMed Web of Science ®Google Scholar
• Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev. 2012;25(4):682–707. doi:10.1128/CMR.05035-11
   PubMed Web of Science ®Google Scholar
• Di Tella D, Tamburro M, Guerrizio G, et al. Molecular epidemiological insights into colistin-resistant and carbapenemases-producing clinical Klebsiella pneumoniae Isolates. Infect Drug Resist. 2019;12:3783–3795. doi:10.2147/IDR.S226416
   PubMed Web of Science ®Google Scholar
• Gao B, Li X, Yang F, et al. Molecular epidemiology and risk factors of ventilator-associated pneumonia infection caused by carbapenem-resistant Enterobacteriaceae. Front Pharmacol. 2019;10:262. doi:10.3389/fphar.2019.00262
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhao C, Chen H, et al. A multicenter epidemiology study on the risk factors and clinical outcomes of nosocomial intra-abdominal infections in China: results from the Chinese Antimicrobial Resistance Surveillance of Nosocomial Infections (CARES) 2007–2016. Infect Drug Resist. 2018;11:2311–2319. doi:10.2147/IDR.S182180
   PubMed Web of Science ®Google Scholar
• Sannathimmappa MB, Nambiar V, Aravindakshan R. Antibiotic resistance pattern of Acinetobacter baumannii Strains: a retrospective study from Oman. Saudi J Med Med Sci. 2021;9(3):254–260. doi:10.4103/sjmms.sjmms_855_20
   Web of Science ®Google Scholar
• Wang H, Wang H, Yu X, et al. Impact of antimicrobial stewardship managed by clinical pharmacists on antibiotic use and drug resistance in a Chinese hospital, 2010–2016: a retrospective observational study. BMJ Open. 2019;9(8):e026072. doi:10.1136/bmjopen-2018-026072
   PubMed Web of Science ®Google Scholar
• Zeng S, Xu Z, Wang X, et al. Time series analysis of antibacterial usage and bacterial resistance in China: observations from a tertiary hospital from 2014 to 2018. Infect Drug Resist. 2019;12:2683–2691. doi:10.2147/IDR.S220183
   Web of Science ®Google Scholar
• Kim B, Kim Y, Hwang H, et al. Trends and correlation between antibiotic usage and resistance pattern among hospitalized patients at university hospitals in Korea, 2004 to 2012: a nationwide multicenter study. Medicine. 2018;97(51):e13719. doi:10.1097/MD.0000000000013719
   PubMed Web of Science ®Google Scholar
• Abbara S, Pitsch A, Jochmans S, et al. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit. Int J Antimicrob Agents. 2019;53(4):416–422. doi:10.1016/j.ijantimicag.2018.12.001
   PubMed Web of Science ®Google Scholar
• Karakonstantis S, Kritsotakis EI, Gikas A. Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems. Infection. 2020;48(6):835–851. doi:10.1007/s15010-020-01520-6
   PubMed Web of Science ®Google Scholar